官方通报：Babycare纸尿裤甲酰胺未检出

Key update: Regulators have issued an authoritative conclusion on the formamide issue in infant diapers. None of the 368 finished-product batches or 32 location-specific samples tested positive for formamide, including Babycare products.

1. Babycare responded that its products are safe for use and announced the establishment of a million-yuan testing fund, opening 100 spots for a "you choose, we test" initiative, where the public can select products and channels for third-party testing with public results.

2. Earlier, Babycare had already verified that 148 of its products were free of formamide; from 2022 through June 2026, market regulators nationwide sampled 150 batches of its diapers across 25 provinces, with a 100% pass rate.

3. The product traceability code allows consumers to view full-link reports on raw materials, production, and testing, as well as 24-hour cloud monitoring of production lines. The Huzhou factory has more than 550 quality control checkpoints and can accurately detect foreign objects as small as 0.5 square millimeters.

4. Consumers can access test reports through the traceability code on packaging, official customer service, or the flagship store, and can also apply for free testing or tours of the transparent factory.

Brand-building insights: Babycare strengthened brand trust through proactive response, authoritative backing, and transparency measures—a model worth learning from.

1. Brand marketing: It used the joint notification from four national departments as a trust signal, emphasizing safe use, while launching a million-yuan testing fund and opening the "you choose, we test" initiative to turn public oversight into a brand communication point.

2. Channel and user communication: Test reports were made accessible through official customer service, flagship stores, and traceability codes, and the transparent factory in Asia was opened for visits to bring the brand closer to users.

3. Product and R&D: The diapers include routine control of 292 risk substances, incorporate screening for more than 1,000 risk substances into internal controls, and ensure safety through toxicology tests and human patch tests on sensitive skin.

4. Consumption trends and user behavior: Consumers are highly sensitive to the safety of maternal and infant products, making transparency, traceability, and third-party testing key trust factors. The free sampling event saw 40,000 units grabbed within 9 minutes on the first day, and 130,000 packs attracted 710,000 people, demonstrating the strong appeal of experiential marketing and cost-effective trials.

Policy and event interpretation: The formamide controversy over baby diapers now has an authoritative investigation result—368 finished batches and 32 location-specific samples all tested negative for formamide, temporarily removing the industry-level risk.

1. Positive impact: All 168 domestic manufacturers, 180 brands, and 368 batches were comprehensively sampled, and the results were safe, helping restore consumer confidence in the diaper category and reducing returns and trust crises.

2. Opportunity note: Babycare has built trust through measures such as the million-yuan testing fund, "you choose, we test," the transparent factory, and traceability codes. Sellers can learn from this transparent service approach to improve conversion rates and repeat purchases.

3. Market shift: Diaper consumers are paying more attention to safety test details, raw material traceability, and visible production. It is recommended to highlight test reports, regulatory compliance, and quality control checkpoints on product pages.

4. Risk reminder: Although the current samples all passed, regulators and public opinion remain highly focused on the safety of maternal and infant products. Sellers should continuously improve incoming inspection and retain test reports to avoid being implicated by individual batch issues.

Production and design requirements: The article highlights the high standards for safety quality control and transparency in baby diaper factories.

1. Product safety design: The entire production line is equipped with more than 550 quality control checkpoints, monitored in real time by an AI-powered "Cloud Eye" intelligent control system that can accurately identify foreign objects as small as 0.5 square millimeters. This points OEM and manufacturing operations toward equipment upgrades and quality inspection investment.

2. Full-process traceability: Consumers can access all test reports from raw materials, production workshop equipment, and finished products, and can request 24-hour cloud monitoring. This means factories must have data collection, storage, and real-time display capabilities, driving digital management.

3. Standards and testing: Products must meet multiple regulatory standards from China, the EU, and the US, and undergo toxicology tests and human skin patch tests on sensitive skin. The company has also incorporated screening for more than 1,000 risk substances into its internal controls. Factories should build broader risk substance lists and third-party testing coordination mechanisms.

4. Business opportunity: For equipment makers and service providers with capabilities in high-precision visual inspection, AI quality control, and full-chain traceability systems, the transparent factory model will fuel demand for technology upgrades.

Industry trend: Maternal and infant consumer products are moving beyond simple safety compliance toward a transparent, verifiable, and participatory quality trust system.

1. Customer pain points: Consumers are highly sensitive to diaper safety, and brands need to prove that their products are free of risk substances across all batches and all parts. Companies face the challenges of high testing costs, long traceability chains, and difficulty building credibility.

2. New technology applications: Babycare uses an AI-powered "Cloud Eye" intelligent control system to monitor production lines in real time and identify foreign objects as small as 0.5 square millimeters, demonstrating the practical value of visual inspection and AI quality control in consumer goods manufacturing.

3. Solution opportunities: The million-yuan testing fund and "you choose, we test" model require independent third-party testing institutions, random sampling processes, and result disclosure platforms; full-chain traceability codes require technical support such as data middle platforms and anti-counterfeiting traceability systems.

4. Expanded services: Transparent factory tours, cloud monitoring, and online access to test reports require supporting capabilities such as digital display, video surveillance, and content management systems, creating development and maintenance demand for service providers.

Platform requirements and practices: After safety incidents in the maternal and infant diaper category, e-commerce platforms can introduce more transparent testing and display mechanisms.

1. Merchant management: Platforms can require diaper merchants to provide authoritative test reports and product traceability code information, and make it easy for consumers to query this information on product pages or details, as Babycare does, lowering the trust barrier.

2. Merchant recruitment and operations: Babycare ranks among the top three in China's diaper market share and first in brand, with sales reaching Southeast Asia, the Middle East, and the US, making it a key target for platform recruitment and support. Its free sampling event sold out within 9 minutes of launch, and platforms can coordinate marketing traffic support.

3. Risk mitigation: In response to diaper-related public opinion events, platforms should promptly link to authoritative sampling results to avoid penalizing compliant merchants. They can also establish a dedicated section for risk substance testing, publishing pass data to help consumers make informed choices.

4. Platform tools: The "you choose, we test" model is suitable for platforms to develop a supervision entry point, where consumers select products and channels and third parties conduct sampling and testing. Platforms, as information display and process managers, can enhance governance credibility.

Industry new dynamics: The maternal and infant diaper industry has formed a safety trust-building mechanism through regulatory intervention and corporate self-certification.

1. Policy and regulatory insights: A joint investigation team from four national departments conducted comprehensive sampling of all manufacturers and OEMs in the industry, using a two-tier approach of full finished-product testing plus location-specific sample testing. This regulatory model can serve as a reference for other high-risk consumer products.

2. Business model innovation: Babycare established a million-yuan testing fund and opened "you choose, we test" supervision slots, where independent third parties conduct random sampling and testing and disclose results. In essence, this brings public oversight into the quality management system, forming a new trust mechanism of third-party co-governance.

3. Corporate case: Babycare's full-chain traceability, AI "Cloud Eye" intelligent control, more than 550 quality control checkpoints, nine-tier checks, routine control of 292 risk substances, and screening of more than 1,000 risk substances demonstrate the refined management level of consumer goods companies from raw materials to finished products.

4. Consumer behavior: The free sampling event saw 130,000 packs attract more than 710,000 buyers, offering a basis for studying the conversion effect of experiential marketing in highly sensitive categories. At the same time, consumer attention to transparent factories and cloud monitoring shows that supply chain transparency is becoming a brand asset.